Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alicia Alpuente

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Cephalalgia : an International Journal of Headache|August 9, 2023
Impact of anti-CGRP monoclonal antibodies on migraine attack accompanying symptoms: A real-world evidence studyAlicia Alpuente, Anna Torre-Sune, Edoardo Caronna, et al.
Cephalalgia : an International Journal of Headache|February 2, 2024
Improvement of migraine depressive symptoms is not related to headache frequency: exploring the impact of anti-CGRP therapiesMarta Torres-Ferrús, Victor J Gallardo, Alicia Alpuente, et al.
Cephalalgia : an International Journal of Headache|August 26, 2020
Neurophysiological correlates of abnormal auditory processing in episodic migraine during the interictal periodAdrià Vilà-Balló, Angela Marti-Marca, Marta Torres-Ferrús, et al.
Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses|January 11, 2025
Quality of Headache Management in InpatientsEulalia Gine-Cipres, Marta Torres-Ferrus, Victor J Gallardo, et al.
The Journal of Headache and Pain|February 12, 2024
Early and annual projected savings from anti-CGRP monoclonal antibodies in migraine prevention: a cost-benefit analysis in the working-age populationCarlos Lazaro-Hernandez, Edoardo Caronna, Joana Rosell-Mirmi, et al.
Epilepsy & Behavior Case Reports|March 6, 2019
Perampanel: A therapeutic alternative in refractory status epilepticus associated with MELAS syndromeEstevo Santamarina, Alicia Alpuente, Olga Maisterra, et al.
Headache|February 19, 2020
How Does Migraine Change After 10 Years? A Clinical Cohort Follow-Up AnalysisEdoardo Caronna, Victor José Gallardo, Elena Fonseca, et al.
Revista De Neurologia|March 31, 2026
Optimizing Chronic Migraine Care: The Impact of Advanced Practice Nurse Involvement in OnabotulinumtoxinA AdministrationEulalia Gine-Cipres, Marta Torres-Ferrus, Víctor J Gallardo, et al.
European Journal of Neurology|September 17, 2024
"Code Headache": Development of a protocol for optimizing headache management in the emergency roomJavier A Membrilla, Alicia Alpuente, Laura Gómez-Dabo, et al.
Toxins|May 24, 2024
Effectiveness and Safety of OnabotulinumtoxinA in Adolescent Patients with Chronic MigraineLaura Gómez-Dabó, Edoardo Caronna, Rut Mas-de-Les-Valls, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Cephalalgia : an International Journal of Headache|August 9, 2023
Impact of anti-CGRP monoclonal antibodies on migraine attack accompanying symptoms: A real-world evidence studyAlicia Alpuente, Anna Torre-Sune, Edoardo Caronna, et al.
Cephalalgia : an International Journal of Headache|February 2, 2024
Improvement of migraine depressive symptoms is not related to headache frequency: exploring the impact of anti-CGRP therapiesMarta Torres-Ferrús, Victor J Gallardo, Alicia Alpuente, et al.
Cephalalgia : an International Journal of Headache|August 26, 2020
Neurophysiological correlates of abnormal auditory processing in episodic migraine during the interictal periodAdrià Vilà-Balló, Angela Marti-Marca, Marta Torres-Ferrús, et al.
Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses|January 11, 2025
Quality of Headache Management in InpatientsEulalia Gine-Cipres, Marta Torres-Ferrus, Victor J Gallardo, et al.
The Journal of Headache and Pain|February 12, 2024
Early and annual projected savings from anti-CGRP monoclonal antibodies in migraine prevention: a cost-benefit analysis in the working-age populationCarlos Lazaro-Hernandez, Edoardo Caronna, Joana Rosell-Mirmi, et al.
Epilepsy & Behavior Case Reports|March 6, 2019
Perampanel: A therapeutic alternative in refractory status epilepticus associated with MELAS syndromeEstevo Santamarina, Alicia Alpuente, Olga Maisterra, et al.
Headache|February 19, 2020
How Does Migraine Change After 10 Years? A Clinical Cohort Follow-Up AnalysisEdoardo Caronna, Victor José Gallardo, Elena Fonseca, et al.
Revista De Neurologia|March 31, 2026
Optimizing Chronic Migraine Care: The Impact of Advanced Practice Nurse Involvement in OnabotulinumtoxinA AdministrationEulalia Gine-Cipres, Marta Torres-Ferrus, Víctor J Gallardo, et al.
European Journal of Neurology|September 17, 2024
"Code Headache": Development of a protocol for optimizing headache management in the emergency roomJavier A Membrilla, Alicia Alpuente, Laura Gómez-Dabo, et al.
Toxins|May 24, 2024
Effectiveness and Safety of OnabotulinumtoxinA in Adolescent Patients with Chronic MigraineLaura Gómez-Dabó, Edoardo Caronna, Rut Mas-de-Les-Valls, et al.
Pageof 6